Vanessa Broadhurst is the Executive Vice President of Global Corporate Affairs and an executive committee member at Johnson & Johnson. Vanessa is responsible for advancing strategies across Corporate Marketing, Global Communications, Global Health Equity, and Worldwide Government Affairs & Policy. She leads and mentors a world-class team who are passionate about transforming health for humanity.
Vanessa has more than 25 years of senior leadership experience, having worked for leading global healthcare companies in the U.S. and Europe including Amgen, Novartis, and Abbott.
Prior to her current position, Vanessa served as Company Group Chairman of Global Commercial Strategy for Johnson & Johnson’s Innovative Medicine sector, where she led efforts focused on commercialization and launch strategies that spanned a broad pipeline of products and realized accelerated business growth across six therapeutic areas. During her tenure, Vanessa was a member of the Pharmaceuticals Group Operating Committee, the Research and Development Senior Leadership Team, and responsible for Global Value and Access, Global Commercial Data Sciences, and Global Medical Affairs.
At Johnson & Johnson Vanessa has led several of its U.S. businesses including Cardiovascular and Metabolism, Internal Medicine, and Infectious Disease, where she consistently delivered significant bottom-line growth and helped grow Johnson & Johnson to become one of the largest and most diversified healthcare companies in the world.
Vanessa sits on the Board of Directors of Zoetis and is a member of The Executive Leadership Council (ELC).
Vanessa holds a Master of Business Administration from the Ross School of Business at the University of Michigan and a Bachelor of Arts degree from the University of Colorado, Boulder.